Work

499 Very-early Viral Response (week-1) to Triple Therapy With Telaprevir, Peg-interferon and Ribavirin Predicts Extended-rvr and Treatment Outcomes in Patients With Hcv Genotype 1

Year: 2013

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(13)60501-2

Authors: K. Takaguchi, H. Toyota, T. Seno, N. Baba, T. Nagano, T. Kumada, K. Kato, N. Shimada, T. Ide, M. Sata, A. Tsubota, N. Izumi

Institutions: Karolinska Institutet, Kagawa Prefectural Central Hospital, Ogaki Municipal Hospital, Ninewells Hospital, Shinmatsudo Central General Hospital, Kurume University, KU Leuven, Jikei University School of Medicine, Musashino Red Cross Hospital

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2027469418

FWCI: 0.182

Cites:

Cited by: 1

Related to: 10